The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action
Guillain-Barré syndrome (GBS) is the most frequent cause of acute flaccid paralysis and, despite treatment, there continues to be an associated mortality and severe disability ranging from 9 to 17%. This article reviews the rationale behind the existing immunotherapy in GBS and discusses the future...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Published: |
Informa Healthcare
2011
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/1935/ http://www.ncbi.nlm.nih.gov/pubmed/21473704 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|